Ligand validation:2XWJ

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 2XWJ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2XWJ_NAG_I_1353	23%	55%	0.228	0.85	0.42	1.3	-	1	0	0	100%	0.9333
2XWJ_NAG_J_1353	16%	69%	0.273	0.84	0.53	0.66	-	-	1	0	100%	0.9333
2XWJ_NAG_L_1353	6%	70%	0.341	0.77	0.54	0.63	-	-	0	0	100%	0.9333
2XWJ_NAG_H_1917	4%	57%	0.345	0.723	0.48	1.17	-	2	0	0	100%	0.9333
2XWJ_NAG_D_1917	4%	56%	0.371	0.732	0.5	1.18	-	1	1	0	100%	0.9333
2XWJ_NAG_K_1353	3%	34%	0.328	0.665	0.57	1.98	-	3	5	0	100%	0.9333
2XWJ_NAG_B_1917	2%	59%	0.43	0.732	0.52	1.05	-	1	0	0	100%	0.9333
2XWJ_NAG_F_1917	2%	64%	0.446	0.712	0.51	0.86	-	-	0	0	100%	0.9333
2OK5_NAG_A_1260	50%	47%	0.159	0.91	0.52	1.51	-	3	0	0	100%	0.9333
3HS0_NAG_A_9187	50%	56%	0.187	0.937	0.45	1.21	-	2	2	0	100%	0.9333
3HRZ_NAG_D_9117	33%	52%	0.232	0.91	0.45	1.4	-	3	0	0	100%	0.9333
7NOZ_NAG_F_801	25%	61%	0.213	0.846	0.5	0.99	-	1	0	0	100%	0.9333
2XWB_NAG_F_1747	18%	68%	0.26	0.848	0.58	0.67	-	-	0	1	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
5O59_NAG_A_601	100%	70%	0.024	0.993	0.3	0.85	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.